SenesTech (SNES) Stock

SenesTech, Inc. (NASDAQ:SNES ) Q3 2024 Earnings Conference Call November 12, 2024 5:00 PM ET Company Participants Robert Blum - Lytham Partners Joel Fruendt - Chief Executive Officer Tom Chesterman - Chief Financial Officer Operator Good day and welcome to the SenesTech Third Quarter Fiscal Year 2024 Financial Results Conference Call. All participants will be in a listen-only mode for the duration of the call.

Significantly Expanding Market Reach PHOENIX , Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), a leader in fertility control solutions for managing animal pest populations, is excited to announce a significant expansion in the distribution of its groundbreaking rodent birth control product. Evolve™ Rat and Evolve™ Mouse are now available on Walmart Marketplace, one of the largest and most trusted eCommerce platforms in the world.

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , Nov. 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on Tuesday, November 12, 2024. The Company has scheduled a conference call that same day, Tuesday, November 12, 2024, at 5:00 pm ET, to review the results.

PHOENIX , Sept. 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today it will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually on Tuesday, October 1, 2024.

PHOENIX , Aug. 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today the closing of an exercise of certain existing warrants to purchase 505,502 shares of the Company's common stock at a reduced exercise price of $4.60 per share. In addition, the Company issued new warrants, as described below.

Record Revenue and Margin Performance PHOENIX , Aug. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the second quarter of 2024. Recent Highlights Record revenues of $874,000 in the first half of 2024, an increase of 62% compared to the first half of 2023.

Common Stock Will Begin Trading on a Split-Adjusted Basis on July 25, 2024 PHOENIX , July 23, 2024 /PRNewswire/ -- SenesTech, Inc.  (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares. The reverse stock split will become effective at 4:01 p.m, Eastern Time, on July 24, 2024.

SenesTech (SNES) looks to leverage the convenience and reach of e-commerce to expand its market share.

PHOENIX , May 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024. Company Webcast The webcasted presentation will take place at 11:45am ET on Thursday, May 30, 2024.